von Tobias Borgers | Sep 5, 2020 | Glaxo
Global Clavulanic Acid Industry Amid Global COVID-19 Crisis: Report Hive Viewpoint Los Angeles, United States, Sept 2020: Global Clavulanic Acid Market report offers a detailed Outlook and future prospects of the Industry. The Clavulanic Acid Market report includes...
von Tobias Borgers | Jul 15, 2020 | Glaxo
Global Prurigo Nodularis Treatment Market Size, Status and Forecast 2020-2026 The report will make detailed analysis mainly on in-depth research on the development environment, Market size, development trend, operation situation and future development trend of Prurigo...
von Tobias Borgers | Mai 22, 2020 | Glaxo
Nanopharmaceuticals Market 2020 report covers key business segments and wide scope geographies to get deep dive analyzed industry data. The company profiles of top Market players will provide financial analysis listing the company revenue, and market share. The past...
von Tobias Borgers | Mai 21, 2020 | Glaxo
AstraZeneca has secured over $1 billion from the HHS‘ Biomedical Advanced Research and Development Authority (BARDA) to develop and supply its Oxford University-partnered vaccine. China’s CanSino Biologics, already the development frontrunner with a...
von Tobias Borgers | Feb 11, 2020 | Glaxo
The company announced that these changes are a result of its transformation plan, which will see GSK split its consumer healthcare business from its core operations.According to the company, the ‘new GSK’ that will be formed following that separation will see it focus...
von Tobias Borgers | Nov 23, 2019 | Glaxo
MISSISSAUGA, ON, Nov. 22, 2019 /CNW/ – GSK is proud to be named as one of Canada’s Top 100 Employers. The prestigious award underscore GSK’s values-based culture and strong commitment to creating an environment where employees can be their authentic...
